Vertex Pharmaceuticals Stock Soaring: Is More Upside Ahead?
Vertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
Identifying which cash back cards are worth it can enhance your financial strategy. Explore the top options for maximizing rewards.
25,607 articlesVertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
Investors chasing income are eyeing three high-yield dividend stocks flashing warning signs as coverage tightens and ...
AI memory demand sent memory-chipmakers like Micron and SK Hynix soaring. But the investing legend John Templeton wou...
Investors are watching Nextdoor's 2025 earnings closely as the Q4 results shed light on monetization of local communi...
A dramatic surge in a single year can turn heads, but investors need more than headlines. This article dives into whe...
As Walmart introduces a new chief executive in 2026, investors weigh whether the company can sustain growth, expand m...
Institutional moves can reveal where smart money sees durable cash flow. Learn why ancora advisors opens $148 million...
Goldman Sachs upgrades Liberty Energy and Patterson-UTI after surprising Q4 results, highlighting a growing gap betwe...
As Gap readies its (gap) 2025 earnings call, investors want clarity on brand performance, margins, and 2026 guidance....
As SuRo Capital releases its Q4 2025 results, investors need a clear playbook. This deep dive breaks down the key met...
Figma stock has fallen in 2026 as AI-powered competitors gain ground. This guide breaks down whether the decline crea...
Investors are shifting focus from Intel to overlooked chip stocks delivering real cash flow and AI-driven demand, led...